Cyclin-dependent kinase 4/6 inhibitors palbociclib or ribociclib combined with endocrine therapy and radiation therapy for patients with metastatic breast cancer

被引：0
|
作者：
Ratosa, I. [1 ]
Scoccimarro, E. [2 ,3 ]
Dominici, L. [2 ,3 ]
Orazem, M. [1 ]
Steinacher, M. [4 ]
Aquilano, M. [2 ,3 ]
Cerbai, C. [2 ,3 ]
Desideri, I. [2 ,3 ]
Marinko, T. [1 ]
Livi, L. [2 ,3 ]
Meattini, I. [2 ,3 ]
机构：
[1] Inst Oncol, Div Radiat Oncol, Ljubljana, Slovenia
[2] Univ Florence, Dept Expt & Clin Biomed Sci M Serio, Florence, Italy
[3] Azienda Osped Univ Careggi, Radiat Oncol Unit, Dept Oncol, Florence, Italy
[4] Univ Med Ctr Maribor, Dept Oncol, Maribor, Slovenia
来源：
EUROPEAN JOURNAL OF CANCER | 2020年 / 138卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
262
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [1] Cyclin-dependent kinase 4/6 inhibitors in breast cancer: palbociclib, ribociclib, and abemaciclib
    Kwapisz, Dorota
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (01) : 41 - 54
  • [2] Cyclin-dependent kinase 4/6 inhibitors in breast cancer: palbociclib, ribociclib, and abemaciclib
    Dorota Kwapisz
    Breast Cancer Research and Treatment, 2017, 166 : 41 - 54
  • [3] Cyclin-dependent kinase 4/6 inhibitors in breast cancer therapy
    Migliaccio, Ilenia
    Di Leo, Angelo
    Malorni, Luca
    CURRENT OPINION IN ONCOLOGY, 2014, 26 (06) : 568 - 575
  • [4] Cyclin-Dependent Kinase 4/6 Inhibitors Combined With Radiotherapy for Patients With Metastatic Breast Cancer
    Ratosa, Ivica
    Orazem, Miha
    Scoccimarro, Erika
    Steinacher, Mateja
    Dominici, Luca
    Aquilano, Michele
    Cerbai, Cecilia
    Desideri, Isacco
    Ribnikar, Domen
    Marinko, Tanja
    Livi, Lorenzo
    Meattini, Icro
    CLINICAL BREAST CANCER, 2020, 20 (06) : 495 - 502
  • [5] Clinical Pharmacokinetics and Pharmacodynamics of the Cyclin-Dependent Kinase 4 and 6 Inhibitors Palbociclib, Ribociclib, and Abemaciclib
    Stefanie L. Groenland
    Alejandra Martínez-Chávez
    Marloes G. J. van Dongen
    Jos H. Beijnen
    Alfred H. Schinkel
    Alwin D. R. Huitema
    Neeltje Steeghs
    Clinical Pharmacokinetics, 2020, 59 : 1501 - 1520
  • [6] Clinical Pharmacokinetics and Pharmacodynamics of the Cyclin-Dependent Kinase 4 and 6 Inhibitors Palbociclib, Ribociclib, and Abemaciclib
    Groenland, Stefanie L.
    Martinez-Chavez, Alejandra
    van Dongen, Marloes G. J.
    Beijnen, Jos H.
    Schinkel, Alfred H.
    Huitema, Alwin D. R.
    Steeghs, Neeltje
    CLINICAL PHARMACOKINETICS, 2020, 59 (12) : 1501 - 1520
  • [7] Cyclin-Dependent Kinase 4/6 Inhibitors in Neoadjuvant Endocrine Therapy of Hormone Receptor-Positive Breast Cancer
    Rossi, Lorenzo
    McCartney, Amelia
    Risi, Emanuela
    De Santo, Irene
    Migliaccio, Ilenia
    Malorni, Luca
    Biganzoli, Laura
    Di Leo, Angelo
    CLINICAL BREAST CANCER, 2019, 19 (06) : 392 - 398
  • [8] Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment
    Iuliani, Michele
    Simonetti, Sonia
    Ribelli, Giulia
    Napolitano, Andrea
    Longo, Umile Giuseppe
    Vincenzi, Bruno
    Orsaria, Paolo
    Denaro, Vincenzo
    Tonini, Giuseppe
    Santini, Daniele
    Francesco, Pantano
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)
  • [9] Effect of Cyclin-Dependent Kinase 4/6 Inhibitors on CirculatingCells in Patients with Metastatic Breast Cancer
    Lobo-Martins, Soraia
    Corredeira, Patricia
    Cavaco, Ana
    Rodrigues, Carolina
    Piairo, Paulina
    Lopes, Claudia
    Fraga, Joana
    Silva, Madalena
    Alves, Patricia
    Szeneszi, Lisiana Wachholz
    Barradas, Ana
    Duran, Camila Castro
    Antunes, Marilia
    Nogueira-Costa, Goncalo
    Sousa, Rita
    Pinto, Conceicao
    Ribeiro, Leonor
    Abreu, Catarina
    Torres, Sofia
    Quintela, Antonio
    Mata, Gadea
    Megias, Diego
    Ribot, Julie
    Serre, Karine
    Casimiro, Sandra
    Silva-Santos, Bruno
    Dieguez, Lorena
    Costa, Luis
    CELLS, 2024, 13 (16)
  • [10] A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients
    Guerini, Andrea Emanuele
    Pedretti, Sara
    Salah, Emiliano
    Simoncini, Edda Lucia
    Maddalo, Marta
    Pegurri, Ludovica
    Pedersini, Rebecca
    Vassalli, Lucia
    Pasinetti, Nadia
    Peretto, Gloria
    Triggiani, Luca
    Costantino, Gianluca
    Figlia, Vanessa
    Alongi, Filippo
    Magrini, Stefano Maria
    Buglione, Michela
    SCIENTIFIC REPORTS, 2020, 10 (01)
12345